Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...
A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.
A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...
Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic ...
Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Brainstorm Cell Therapeutics (BCLI – Research Report). The ...
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...
Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.
(Lawrenceburg, IN) – The 8th annual Cruisin’ to a Cure for ALS (Amyotrophic Lateral Sclerosis) car show in Lawrenceburg set ...
About Rozebalamin (generic name: mecobalamin, development code: E0302) ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar ...
Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has received three grants totaling more ...